Fresenius Medical Care AG (FMCQF) Receivables - Other (2016 - 2025)
Fresenius Medical Care AG has reported Receivables - Other over the past 17 years, most recently at $144.7 million for Q4 2025.
- Quarterly results put Receivables - Other at $144.7 million for Q4 2025, up 24.3% from a year ago — trailing twelve months through Dec 2025 was $144.7 million (up 24.3% YoY), and the annual figure for FY2025 was $144.7 million, up 24.3%.
- Receivables - Other for Q4 2025 was $144.7 million at Fresenius Medical Care AG, up from $116.4 million in the prior quarter.
- Over the last five years, Receivables - Other for FMCQF hit a ceiling of $250.5 million in Q4 2023 and a floor of $116.4 million in Q4 2024.
- Median Receivables - Other over the past 5 years was $152.4 million (2021), compared with a mean of $173.3 million.
- Biggest five-year swings in Receivables - Other: soared 48.22% in 2021 and later crashed 53.54% in 2024.
- Fresenius Medical Care AG's Receivables - Other stood at $152.4 million in 2021, then soared by 32.93% to $202.6 million in 2022, then increased by 23.68% to $250.5 million in 2023, then crashed by 53.54% to $116.4 million in 2024, then increased by 24.3% to $144.7 million in 2025.
- The last three reported values for Receivables - Other were $144.7 million (Q4 2025), $116.4 million (Q4 2024), and $250.5 million (Q4 2023) per Business Quant data.